Estrogen modulates the recruitment of myelopoietic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis

Blood

Volumn 87, Issue 7, 1996, Pages 2683-2692

  Shevde, Nirupama K ^a   Pike, J Wesley ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RALOXIFENE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE REMODELING; CLONOGENIC ASSAY; COLONY FORMING UNIT GM; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HEMATOPOIETIC STEM CELL; HORMONAL REGULATION; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; STROMA CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029879662     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.7.2683.bloodjournal8772683     Document Type: Article

References (50)

1. Parfitt AM: Quantum concept of bone remodeling and turn-over: Implications for the pathogenesis of osteoporosis. Calcif Tissue Int 28:1-5, 1979
2. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS: Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis: Implications for the microanatomic and cellular mechanism of bone loss. J Clin Invest 72:1396, 1983
3. Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Meisen F: A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 10:313, 1989
4. Ericksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL: Cancellous bone remodeling in type I (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 5:311, 1990
5. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson KB, Clarke AC: Long-term prevention of postmenopausal osteoporosis by estrogen. Lancet 1:1038, 1976
6. Hutchinson TA, Polansky SM, Feinstein AR: Postmenopausal oestrogens protect against fractures of hip and distal radium. Lancet 2:705, 1979
7. Ettinger B, Genant HK, Cann CE: Long term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 102:319, 1985
8. Genant HK, Baylink DJ, Gallagher JC: Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161:1842, 1989
9. Mack TM, Ross RK: Risks and benefits of long-term treatment with estrogens. Schweiz Med Wochenschr Suppl 119:1811, 1989
10. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328:1069, 1993
11. Turner RT, Riggs BL, Spelsberg TC: Skeletal effects of estrogen. Endocrine Rev 15:275, 1994
12. Ernst M, Heath JK, Rodan GA: Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-1, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825, 1989
13. Ericksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL: Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84, 1988
14. Komm BS, Terpening CM, Benz DJ, Graeme KA, O'Malley BW, Haussler MR: Estrogen binding receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science 241:81, 1988
15. Kalu DN: Proliferation of tartrate-resistant acid phosphatase positive multinucleated cells in ovariectomized animals. Proc Soc Exp Biol Med 195:70, 1990
16. Girasole G, Jilka RL, Passen G, Boswell S, Boder G, Williams DC, Manolagas SC: 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883, 1992
17. Dexter TM, Allen TD, Lajtha LG: Conditions controlling the proliferation of hematopoietic stem cells. J Cell Physiol 91:335, 1977
18. Horowitz MC, Jilka RL: Colony stimulating factors and bone remodeling, in Gowen M, Russell RGG (eds): Cytokines and Bone Metabolism. Boca Raton, FL, CRC, 1992, p 185
19. Shevde N, Anklesaria P, Greenberger JS, Bleiberg I, Glowacki J: Stromal cell-mediated stimulation of osteoclastogenesis. Proc Soc Exp Biol Med 205:306, 1993
20. Mundy GR: Cytokines and local factors which affect osteoclast function. Int J Cell Clon 10:215, 1992
21. Mundy GR, Roodman GD: Osteoclast ontogeny and function. Bone Min Res 5:209, 1987
22. MacDonald BR, Mundy GR, Clark S, Wang EA, Kuehl TJ, Stanley ER, Roodman GD: Effect of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow culture. J Bone Miner Res 1:227, 1986
23. Liggett W Jr, Shevde N, Anklesaria P, Sohoni S, Greenberger J, Glowacki J: Effects of macrophage colony stimulating factor and granulocyte-macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells. Stem Cells 11:398, 1993
24. 3 on the differentiation of human monocytic cell line. Blood 71:619, 1988
25. 3. Proc Natl Acad Sci USA 80:5907, 1983
26. McSheely PM, Chambers TJ: Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118:824, 1986
27. Jilka RL, Hangoc G, Girasole G, Passen G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC: Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257:88, 1992
28. Pottratz S, Bellido T, Mocharia H, Girasole G, Jilka R, Manolagas SC, Crabb D: 17β-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93:944, 1992
29. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F: Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189, 1994
30. MacDonald BR, Takahashi N, McManus LM, Holahan J, Mundy GR, Roodman GD: Formation of multinucleated cells that respond to osteotropic hormones in long-term human bone marrow cultures. Endocrinology 120:2326, 1986
31. Zipori D, Reichman N, Arcavi L, Shtalrid M, Berrebi A, Resnitzky P: In vitro functions of stromal cells from human and mouse bone marrow. Exp Hematol 13:603, 1985
32. Kerr JR, Harmon BV: Definition and incidence of apoptosis: An historical perspective, in Tomei LD, Cope FO (eds): Apoptosis, the Molecular Basis for Cell Death, vol 3. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1991, pp 5-29
33. Gorczyca W, Bruno RJ, Darzynkiweicz J, Gong J, Darzynkiweicz Z: DNA strand breaks occurring in apoptosis: Their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol 1:639, 1992
34. Gorczyca W, Bigman K, Mittelman P, Ahmed J, Gong J, Malamed MR, Darzynkiweicz Z: Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7:659, 1993
35. Castagnola C, Visser J, Boersma W, von Bekkum DW: Purification of rat pluripotent haematopoietic stem cells. Stem Cell 1:250, 1981
36. McCarthy KF, Hale ML, Fehnel PL: Purification and analysis of rat hematopoietic stem cells by flow cytometry. Cytometry 8:296, 1987
37. King WJ, Greene GL: Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307:745, 1984
38. Soule HD, Vasquez J, Long A, Albert S, Brennan MJ: Human cell line from pleural effusion derived from breast carcinoma. J Natl Cancer Inst 51:1409, 1973
39. Black LJ, Masahiko S, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kauffman RF, Bensch WR, Frolick CA, Termine JD, Bryant HU: Raloxifene (LY 139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63, 1994
40. Goldschneider I, Metcalf D, Mandel T, Bollum FJ: Analysis of rat hematopoietic cells on the fluorescence-activated cell sorter. Isolation of terminal deoxynucleotidyl transferase-positive cells. J Exp Med 152:438, 1980
41. Scheven BAA, Visser JWM, Nijweide PJ: In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Science 321:79, 1986
42. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP: Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endo 8:21, 1994
43. Deryugina EI, Muller-Sieburg CE: Stromal cells in long-term cultures: Keys to the elucidation of hematopoietic development. Crit Rev Immunol 13:115, 1993
44. Suda T, Takahashi N, Martin TJ: Modulation of osteoclast differentiation. Endocrine Rev 13:66, 1992
45. Girasole G, Passeri G, Jilka RL, Manolagas SC: Interleukin-11: A new cytokine critical for osteoclast development. J Clin Invest 93:1516, 1994
46. Tyslowitz R, Dingemanse E: Effect of large doses of estrogen on the blood picture of dogs. Endocrinology 29:817, 1941
47. Fried W, Tichler T, Dennenberg I, Barone J, Wang F: Effects of estrogens on hematopoietic stem cells and on hematopoiesis of mice. J Lab Clin Med 83:807, 1974
48. Landsman N, Bleiberg I: Effect of estradiol on erythropoiesis and megakaryocytopoiesis in mice. Israel J Med 15:140, 1979
49. Egrise D, Martin D, Neve P, Vienne A, Verhas M, Schoutens A: Bone blood flow and in vitro proliferation of bone marrow and trabecular bone osteoblast-like cells in ovariectomized rats. Calcif Tissue Int 50:336, 1992
50. Jilka R, Passeri G, Girasole G, Cooper S, Abrams J, Broxmeyer H and Manolagas S: Estrogen loss upregulates hematopoiesis in the mouse: A mediating role of IL-6. Exp Hematol 23(6):500, 1995